 |
eflornithine + sulindac |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2018-01-08 00:00:00 |
| Sponsor | Cancer Prevention Pharmaceutical, Inc.;1760 East River Road, Suite 250;Tucson, Arizona, 85718 |
| |
eflornithine + sulindac |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic Cancer |
| USA Market Approval | USA |
| USA Designation Date | 2018-01-08 00:00:00 |
| Sponsor | Cancer Prevention Pharmaceutical, Inc.;1760 East River Road, Suite 250;Tucson, Arizona, 85718 |